Skip to content

Drug interactions

Eprosartan-hydrochlorothiazide + Mycophenolate

Severity: Minor

Eprosartan-hydrochlorothiazide and Mycophenolate: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Hydrochlorothiazide may compete with the mycophenolic acid glucuronide metabolite for renal tubular secretion and could raise its levels. The clinical consequence is uncertain but may include increased mycophenolate effects or toxicity.

What this interaction means in plain words

Eprosartan-hydrochlorothiazide and Mycophenolate have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Evidence level: Low

Why it happens

Competition between thiazide and mycophenolic acid glucuronide for renal tubular anionic secretion.

What to do

Monitor for signs of mycophenolate toxicity such as cytopenias and gastrointestinal effects, and check blood counts periodically.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Eprosartan-hydrochlorothiazide and Mycophenolate, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Eprosartan-hydrochlorothiazide with Mycophenolate?

MediHelp rates the interaction as minor. Eprosartan-hydrochlorothiazide and Mycophenolate have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Hydrochlorothiazide may compete with the mycophenolic acid glucuronide metabolite for renal tubular secretion and could raise its levels. The clinical consequence is uncertain but may include increased mycophenolate effects or toxicity.

How serious is the interaction between Eprosartan-hydrochlorothiazide and Mycophenolate?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for signs of mycophenolate toxicity such as cytopenias and gastrointestinal effects, and check blood counts periodically.

What other medicines interact with Eprosartan-hydrochlorothiazide?

MediHelp also lists interactions of Eprosartan-hydrochlorothiazide with, for example, Aliskiren, Dofetilide, Sparsentan. The full list is on the Eprosartan-hydrochlorothiazide page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in